US Patent 12091413 Inhibitors of NEK7 kinase
Patent 12091413 was granted and assigned to Halia Therapeutics, Inc. on September, 2024 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 12091413 Inhibitors of NEK7 kinase
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
